Author

Yuhao Li

Washington University in St. LouisORCID 0000-0003-2413-0937Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Michael S. DiamondiD· 2 shared Ahmed O. HassaniD· 1 shared Andrew H. KimiD· 1 shared Chieh-Yu LiangiD· 1 shared Cory M. AcremaniD· 1 shared Crystal LovatoiD· 1 shared Daniel C. DouekiD· 1 shared Darin K. EdwardsiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Michael S. DiamondORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyPLoS PathogensPeer-reviewedOct 2, 2024

Sequential early-life viral infections modulate the microbiota and adaptive immune responses to systemic and mucosal vaccination

Yuhao Li, Jerome M. Molleston, Crystal Lovato…·Megan T. Baldridge

This study shows that sequential early-life viral infections in mice reduce antibody responses to SARS-CoV-2 vaccination while altering immune cell profiles and gut microbiota.

16 citations

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologyNaturePeer-reviewedMay 15, 2024

Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting

Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu…·Michael S. Diamond

This study shows that Omicron variant-matched boosters after prototype mRNA vaccines induce cross-neutralizing antibodies against SARS-CoV-2 and sarbecoviruses by imprinting prior immune responses.

94 citationstop 1%

humanmouse

𝕏 PostBluesky